NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
March 6, 2026 — Soligenix leverages platform science with synthetic hypericin to treat both CTCL and psoriasis, demonstrating efficient multi-disease drug development through strategic adaptation of core technology.
March 6, 2026 — LIXTE Biotechnology advances LB-100 to sensitize 'cold' tumors to immunotherapy. Learn how this compound could overcome cancer treatment resistance and enhance immune response against malignancies.
March 6, 2026 — 360 Orthodontics in Colton, CA offers affordable braces and Invisalign treatments with flexible payment plans. Learn about their patient-focused care and community involvement for a healthier smile.
March 6, 2026 — 360 Orthodontics in Oxnard, CA offers affordable braces & Invisalign with personalized care plans. Learn about their commitment to quality, flexible payment options, and patient-centered approach for your family's smile.
March 6, 2026 — Tonix Pharmaceuticals publishes peer-reviewed study on FDA-approved TONMYA for fibromyalgia, detailing novel sublingual formulation's pharmacokinetics and improved tolerability profile for chronic pain management.
March 6, 2026 — VolitionRx partners with Fujifilm to automate Nu.Q Vet Cancer Test in Japan, enabling faster results for 1,700+ veterinary hospitals and 7 million pet dogs through IDS i10 platform.
March 6, 2026 — Oregon State University researchers develop iron-based nanomaterial that selectively kills cancer cells while sparing healthy tissue. Breakthrough could revolutionize targeted cancer therapy with fewer side effects.
March 6, 2026 — Fleetmikewood Protocol redefines genetic engineering with AI-driven self-hypnosis for immediate health optimization and transgenerational DNA evolution through epigenetic rewriting.
March 5, 2026 — HeartBeam begins ALIGN-ACS pilot study for heart attack detection using revolutionary 3D ECG technology. First patients enrolled in Serbia for clinical trial expansion beyond arrhythmia assessment.
March 5, 2026 — Lionheart Health appoints renowned neurosurgeon Dr. Joseph Maroon to advisory board, strengthening its bioelectric therapies for brain health and longevity. Learn about innovative treatments for cognition and inflammation reduction.
March 5, 2026 — 360 Orthodontics in Los Angeles offers braces and Invisalign treatments with personalized care plans and affordable financing. Transform your smile with expert orthodontic services.
March 5, 2026 — 360 Orthodontics in Santa Ana offers personalized braces and Invisalign treatments with affordable payment plans. Learn about their expert care and community focus for all ages.
March 5, 2026 — 360 Orthodontics in Santa Clarita provides affordable braces and Invisalign treatments with personalized care and financing options. Learn how they transform smiles.
March 5, 2026 — Florida expert Douglas Halperin shares key tips for choosing assisted living: assess true costs, Medicaid options, and care needs to find the right fit and avoid hidden fees.
March 5, 2026 — Helus Pharma reports positive Phase 2 results for HLP004 in generalized anxiety disorder treatment. Novel serotonergic agonist shows significant anxiety reduction in patients unresponsive to standard therapies.
March 5, 2026 — Aditxt (NASDAQ: ADTX) implements a 1-for-8 reverse stock split effective March 9, 2026, to regain Nasdaq compliance. Learn about this health innovation platform's strategic move.
March 5, 2026 — Soligenix leverages platform technology with synthetic hypericin to treat CTCL & psoriasis. Learn how this efficient "one drug, multiple diseases" model is shaping biotech innovation.
March 5, 2026 — Boston BioLife's Functional Longevity Summit brought together health innovators to discuss personalized medicine, advanced diagnostics, and Therapeutic Plasma Exchange for anti-aging benefits.
March 5, 2026 — HeartBeam begins ALIGN-ACS study for heart attack detection using its FDA-cleared 3D ECG technology. Medical breakthrough enables portable cardiac monitoring outside hospitals.
March 5, 2026 — HeartBeam (NASDAQ: BEAT) announces a conference call on March 12, 2026, to discuss 2025 financial results and updates on its FDA-cleared 12-lead ECG patch technology.